Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 18,493-18,504 of 23,847

Behavioral study icon

CompletedNCT02634684

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego

SchizophreniaBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Schizophrenia

Drug study icon

TerminatedNCT03831113

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Pittsburgh

AddictionDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Steve N. Caritis, MD
Condition: Addiction

Behavioral study icon

CompletedNCT00838981

Pharmacotherapy & CM for Opioid and Cocaine Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Behavioral study icon

CompletedNCT00000281

Pharmacotherapy for Schizophrenic Drug Users - 6

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven

AddictionBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

CompletedNCT00518947

Pharmacotherapy of Treatment-Resistant Mania

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Bipolarity

Drug study icon

TerminatedNCT02374567

Pharmacovigilance in Gerontopsychiatric Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Augsburg

Schizophrenia, Depression, ...DrugOver 65 Years

Countries: Germany
Sponsor: Hannover Medical School
Condition: Schizophrenia, Depression, ...

Behavioral study icon

CompletedNCT00469365

Pharmacy Interventions to Improve Chronic Disease Medication Refill

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston

DepressionBehavioral

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Depression

Other study type icon

CompletedNCT01342120

PHARMO Institute Seroquel Safety Study

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

Depression, Anxiety, ...OtherOver 18 Years

Countries
Sponsor: AstraZeneca
Condition: Depression, Anxiety, ...

Drug study icon

CompletedNCT04987658

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolarity type I

This study is completed in the United States. It is testing OLZ/SAM for Bipolarity.

Multiple locations, including Decatur

BipolarityDrugFrom 10 Years to 12 Years

Countries: United States
Sponsor: Alkermes, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT02748694

Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

This study is completed in the United States. It focuses on Schizophrenia.

In Glendale

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Schizophrenia

Drug study icon

CompletedNCT05845398

Phase 1b Study of DCR-AUD in Healthy Volunteers

This summary needs review. Please check the official study record and contact the research team for details.

In Glendale

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Condition: Addiction

Drug study icon

TerminatedNCT05839509

Phase 2 study of GH001 in Bipolarity type II

This study was terminated in the United Kingdom, in Germany, and in the Netherlands. It is testing Phase 2 Clinical Trial of GH001 for Bipolarity.

Multiple locations, including Dresden

BipolarityDrugFrom 18 Years to 64 Years

Countries: United Kingdom, Germany, Netherlands
Sponsor: GH Research Ireland Limited
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.